Frazier Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Frazier Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-115	Closed	-$3.04K	–	632
2026 Q1	$3.04K	Hold	115	–	–	﹤0.01%	549
2025 Q4	$3.33K	Hold	115	–	–	﹤0.01%	514
2025 Q3	$3.19K	Hold	115	–	–	﹤0.01%	495
2025 Q2	$2.8K	Hold	115	–	–	﹤0.01%	505
2025 Q1	$2.39K	Hold	115	–	–	﹤0.01%	489
2024 Q4	$2.73K	Hold	115	–	–	﹤0.01%	496
2024 Q3	$2.94K	Sell	115 -75	-39%	-$1.91K	﹤0.01%	644
2024 Q2	$4.46K	Hold	190	–	–	﹤0.01%	639
2024 Q1	$5.46K	Hold	190	–	–	﹤0.01%	577
2023 Q4	$6.23K	Buy	+190	New	+$5.17K	0.01%	452

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Frazier Financial Advisors's ARKG Position: Q2 2026 in Review

Frazier Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 115 shares — an estimated $3.04K sold.

Frazier Financial Advisors first reported a position in ARKG in Q4 2023 and held it in 10 quarters. The position peaked at $6.23K in Q4 2023. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Frazier Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Frazier Financial Advisors sold 115 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.04K.
Frazier Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 10 quarters.
Frazier Financial Advisors's ARK Genomic Revolution ETF position peaked at $6.23K in Q4 2023.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.